CMS Establishes National Payment for AI Breakthrough in Prostate Cancer Diagnosis, Unfold AI
CULVER CITY, Calif., July 25, 2024 /PRNewswire/ — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, today announces the Centers for Medicare & Medicaid Services (CMS) has assigned a national payment rate for the company’s innovative prostate cancer mapping technology, Unfold AI. Additionally, effective July 1, 2024, the American Medical Association (AMA) implemented a new Category III code for reimbursement on services related to the use of Unfold AI, marking a major step forward in making this technology more widely available to patients.
